- Home
- AREB vs BOLT Comparison
AREB vs BOLT Comparison
Compare AREB & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- BOLT
- Stock Information
- Founded
- AREB 2014
- BOLT 2015
- Country
- AREB United States
- BOLT United States
- Employees
- AREB N/A
- BOLT N/A
- Industry
- AREB Plastic Products
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- AREB Industrials
- BOLT Health Care
- Exchange
- AREB Nasdaq
- BOLT Nasdaq
- Market Cap
- AREB 8.4M
- BOLT 9.4M
- IPO Year
- AREB N/A
- BOLT 2021
- Fundamental
- Price
- AREB $0.75
- BOLT $4.89
- Analyst Decision
- AREB
- BOLT Buy
- Analyst Count
- AREB 0
- BOLT 3
- Target Price
- AREB N/A
- BOLT $47.50
- AVG Volume (30 Days)
- AREB 385.5K
- BOLT 14.3K
- Earning Date
- AREB 08-12-2025
- BOLT 08-14-2025
- Dividend Yield
- AREB N/A
- BOLT N/A
- EPS Growth
- AREB N/A
- BOLT N/A
- EPS
- AREB N/A
- BOLT N/A
- Revenue
- AREB $9,474,958.00
- BOLT $4,167,000.00
- Revenue This Year
- AREB N/A
- BOLT N/A
- Revenue Next Year
- AREB N/A
- BOLT N/A
- P/E Ratio
- AREB N/A
- BOLT N/A
- Revenue Growth
- AREB N/A
- BOLT N/A
- 52 Week Low
- AREB $0.70
- BOLT $4.59
- 52 Week High
- AREB $193.48
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- AREB 23.14
- BOLT 37.48
- Support Level
- AREB $0.70
- BOLT $4.81
- Resistance Level
- AREB $0.89
- BOLT $5.28
- Average True Range (ATR)
- AREB 0.11
- BOLT 0.27
- MACD
- AREB -0.03
- BOLT -0.01
- Stochastic Oscillator
- AREB 8.80
- BOLT 34.84
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.